NYSE: AVNTAvient Corp Stock
$30.61+0.02 (+0.07%)
Updated Dec 1, 2025
AVNT Price
$30.61
Fair Value Price
N/A
Market Cap
$2.80B
52 Week Low
$27.48
52 Week High
$51.73
P/E
24.69x
P/B
1.18x
P/S
0.93x
PEG
0.46x
Dividend Yield
3.53%
Revenue
$3.25B
Earnings
$113.30M
Gross Margin
32.2%
Operating Margin
7.71%
Profit Margin
3.5%
Debt to Equity
1.55
Operating Cash Flow
$256M
Beta
1.44
Next Earnings
N/A
Ex-Dividend
Dec 12, 2025
Next Dividend
Jan 7, 2026
AVNT Overview
Avient Corporation manufactures specialized polymer materials. Offerings include thermoplastic compounds, plastic colorants and additives, thermoplastic resins, and vinyl resins Known as PolyOne Corporation until 2020/06, Avient was founded in 2000 and is headquartered in Avon Lake, OH.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AVNT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Chemical
Industry Rating
C
AVNT
Ranked#27 of 52
Ranked#27 of 52
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $51.62 | A | |
| $12.30 | A | |
| $53.55 | A |
Be the first to know about important AVNT news, forecast changes, insider trades & much more!
AVNT News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AVNT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AVNT ($30.61) is trading below its intrinsic value of $31.96, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AVNT is good value based on its earnings relative to its share price (24.69x), compared to the US market average (45.08x)
P/E vs Market Valuation
AVNT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more AVNT due diligence checks available for Premium users.
Valuation
AVNT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
24.69x
Industry
-2.58x
Market
45.08x
AVNT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AVNT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
AVNT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.18x
Industry
3.11x
AVNT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AVNT price to earnings growth (PEG)
For valuing profitable companies with growth potential
AVNT is good value based... subscribe to Premium to read more.
PEG Value Valuation
AVNT's financial health
Profit margin
Revenue
$806.5M
Net Income
$32.6M
Profit Margin
4%
AVNT's Earnings (EBIT) of $250.20M... subscribe to Premium to read more.
Interest Coverage Financials
AVNT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.1B
Liabilities
$3.7B
Debt to equity
1.55
AVNT's short-term assets ($1.42B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AVNT's long-term liabilities ($2.97B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AVNT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AVNT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$72.1M
Investing
-$24.7M
Financing
-$75.3M
AVNT's operating cash flow ($256.40M)... subscribe to Premium to read more.
Debt Coverage Financials
AVNT vs Specialty Chemical Stocks
Avient Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.